Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Levothyroxine Sodium Tablets
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Subpotent; 15 month stability
What was recalled
Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR
- Recalling firm
- Alara Pharmaceutical Co
- Origin
- PR, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-104-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Levothyroxine recalls
See all
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.